Design synthesis and evaluation of novel aldose reductase inhibitors: The case of indolyl-sulfonyl-phenols.

MLA

Koutsopoulos, Konstantinos, et al. “Design Synthesis and Evaluation of Novel Aldose Reductase Inhibitors: The Case of Indolyl-Sulfonyl-Phenols.” Bioorganic & Medicinal Chemistry, vol. 28, no. 15, Aug. 2020, p. 115575. EBSCOhost, https://doi.org/10.1016/j.bmc.2020.115575.

APA

Koutsopoulos, K., Lavrentaki, V., Antoniou, I., Kousaxidis, A., Lefkopoulou, M., Tsantili-Kakoulidou, A., Kovacikova, L., Stefek, M., & Nicolaou, I. (2020). Design synthesis and evaluation of novel aldose reductase inhibitors: The case of indolyl-sulfonyl-phenols. Bioorganic & Medicinal Chemistry, 28(15), 115575. https://doi.org/10.1016/j.bmc.2020.115575

Chicago

Koutsopoulos, Konstantinos, Vasiliki Lavrentaki, Ioakeim Antoniou, Antonios Kousaxidis, Matina Lefkopoulou, Anna Tsantili-Kakoulidou, Lucia Kovacikova, Milan Stefek, and Ioannis Nicolaou. 2020. “Design Synthesis and Evaluation of Novel Aldose Reductase Inhibitors: The Case of Indolyl-Sulfonyl-Phenols.” Bioorganic & Medicinal Chemistry 28 (15): 115575. doi:10.1016/j.bmc.2020.115575.